These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22524250)

  • 1. Imidazolopiperazines: lead optimization of the second-generation antimalarial agents.
    Nagle A; Wu T; Kuhen K; Gagaring K; Borboa R; Francek C; Chen Z; Plouffe D; Lin X; Caldwell C; Ek J; Skolnik S; Liu F; Wang J; Chang J; Li C; Liu B; Hollenbeck T; Tuntland T; Isbell J; Chuan T; Alper PB; Fischli C; Brun R; Lakshminarayana SB; Rottmann M; Diagana TT; Winzeler EA; Glynne R; Tully DC; Chatterjee AK
    J Med Chem; 2012 May; 55(9):4244-73. PubMed ID: 22524250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazolopiperazines: hit to lead optimization of new antimalarial agents.
    Wu T; Nagle A; Kuhen K; Gagaring K; Borboa R; Francek C; Chen Z; Plouffe D; Goh A; Lakshminarayana SB; Wu J; Ang HQ; Zeng P; Kang ML; Tan W; Tan M; Ye N; Lin X; Caldwell C; Ek J; Skolnik S; Liu F; Wang J; Chang J; Li C; Hollenbeck T; Tuntland T; Isbell J; Fischli C; Brun R; Rottmann M; Dartois V; Keller T; Diagana T; Winzeler E; Glynne R; Tully DC; Chatterjee AK
    J Med Chem; 2011 Jul; 54(14):5116-30. PubMed ID: 21644570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.
    Nguyen W; Dans MG; Ngo A; Gancheva MR; Romeo O; Duffy S; de Koning-Ward TF; Lowes KN; Sabroux HJ; Avery VM; Wilson DW; Gilson PR; Sleebs BE
    Eur J Med Chem; 2021 Mar; 214():113253. PubMed ID: 33610028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
    Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressing the global antimalarial portfolio: finding drugs which target multiple Plasmodium life stages.
    Smith PW; Diagana TT; Yeung BK
    Parasitology; 2014 Jan; 141(1):66-76. PubMed ID: 23746048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
    Le Manach C; Gonzàlez Cabrera D; Douelle F; Nchinda AT; Younis Y; Taylor D; Wiesner L; White KL; Ryan E; March C; Duffy S; Avery VM; Waterson D; Witty MJ; Wittlin S; Charman SA; Street LJ; Chibale K
    J Med Chem; 2014 Mar; 57(6):2789-98. PubMed ID: 24568587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.
    Kuhen KL; Chatterjee AK; Rottmann M; Gagaring K; Borboa R; Buenviaje J; Chen Z; Francek C; Wu T; Nagle A; Barnes SW; Plouffe D; Lee MC; Fidock DA; Graumans W; van de Vegte-Bolmer M; van Gemert GJ; Wirjanata G; Sebayang B; Marfurt J; Russell B; Suwanarusk R; Price RN; Nosten F; Tungtaeng A; Gettayacamin M; Sattabongkot J; Taylor J; Walker JR; Tully D; Patra KP; Flannery EL; Vinetz JM; Renia L; Sauerwein RW; Winzeler EA; Glynne RJ; Diagana TT
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5060-7. PubMed ID: 24913172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of functionalized phthalimides: a new class of antimalarials and inhibitors of falcipain-2, a major hemoglobinase of malaria parasite.
    Singh AK; Rajendran V; Pant A; Ghosh PC; Singh N; Latha N; Garg S; Pandey KC; Singh BK; Rathi B
    Bioorg Med Chem; 2015 Apr; 23(8):1817-27. PubMed ID: 25766631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
    Hameed P S; Chinnapattu M; Shanbag G; Manjrekar P; Koushik K; Raichurkar A; Patil V; Jatheendranath S; Rudrapatna SS; Barde SP; Rautela N; Awasthy D; Morayya S; Narayan C; Kavanagh S; Saralaya R; Bharath S; Viswanath P; Mukherjee K; Bandodkar B; Srivastava A; Panduga V; Reddy J; Prabhakar KR; Sinha A; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Magistrado PA; Lukens AK; Wirth DF; Waterson D; Balasubramanian V; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK; Ramachandran S
    J Med Chem; 2014 Jul; 57(13):5702-13. PubMed ID: 24914738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasites.
    Glenn MP; Chang SY; Hornéy C; Rivas K; Yokoyama K; Pusateri EE; Fletcher S; Cummings CG; Buckner FS; Pendyala PR; Chakrabarti D; Sebti SM; Gelb M; Van Voorhis WC; Hamilton AD
    J Med Chem; 2006 Sep; 49(19):5710-27. PubMed ID: 16970397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives.
    Ryckebusch A; Deprez-Poulain R; Maes L; Debreu-Fontaine MA; Mouray E; Grellier P; Sergheraert C
    J Med Chem; 2003 Feb; 46(4):542-57. PubMed ID: 12570376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacomodulation on the 3-acetylursolic acid skeleton: Design, synthesis, and biological evaluation of novel N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-O-acetylursolamide derivatives as antimalarial agents.
    Gnoatto SC; Susplugas S; Dalla Vechia L; Ferreira TB; Dassonville-Klimpt A; Zimmer KR; Demailly C; Da Nascimento S; Guillon J; Grellier P; Verli H; Gosmann G; Sonnet P
    Bioorg Med Chem; 2008 Jan; 16(2):771-82. PubMed ID: 17967541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, design, and optimization of a potent and selective series of pyridylpiperazines as promising antimalarial agents.
    da Silva Oliveira DD; Paz F; Brito NPF; Krüger A; Martinho ACC; Lapierre TJWJD; de Oliveira Souza F; Maltarollo VG; Kronenberger T; Mendes MS; Nonato MC; Pilau EJ; Wrenger C; Wunderlich G; Rezende Júnior CO
    Eur J Med Chem; 2024 Sep; 275():116621. PubMed ID: 38944935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite Strains.
    Le Manach C; Paquet T; Wicht K; Nchinda AT; Brunschwig C; Njoroge M; Gibhard L; Taylor D; Lawrence N; Wittlin S; Eyermann CJ; Basarab GS; Duffy J; Fish PV; Street LJ; Chibale K
    J Med Chem; 2018 Oct; 61(20):9371-9385. PubMed ID: 30256636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of imidazo[4,5-c]quinolin-2-ones as gametocytocidal antimalarial agents.
    Patel PR; Sun W; Kim M; Huang X; Sanderson PE; Tanaka TQ; McKew JC; Simeonov A; Williamson KC; Zheng W; Huang W
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2907-2911. PubMed ID: 27156776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers.
    Leong FJ; Zhao R; Zeng S; Magnusson B; Diagana TT; Pertel P
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6437-43. PubMed ID: 25136017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.
    Zhang Y; Clark JA; Connelly MC; Zhu F; Min J; Guiguemde WA; Pradhan A; Iyer L; Furimsky A; Gow J; Parman T; El Mazouni F; Phillips MA; Kyle DE; Mirsalis J; Guy RK
    J Med Chem; 2012 May; 55(9):4205-19. PubMed ID: 22435599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.
    Norcross NR; Baragaña B; Wilson C; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Porzelle A; Grimaldi R; Wittlin S; Duffy S; Avery VM; Meister S; Sanz L; Jiménez-Díaz B; Angulo-Barturen I; Ferrer S; Martínez MS; Gamo FJ; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
    J Med Chem; 2016 Jul; 59(13):6101-20. PubMed ID: 27314305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues.
    Hindley S; Ward SA; Storr RC; Searle NL; Bray PG; Park BK; Davies J; O'Neill PM
    J Med Chem; 2002 Feb; 45(5):1052-63. PubMed ID: 11855985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidines.
    Gonzàlez Cabrera D; Douelle F; Le Manach C; Han Z; Paquet T; Taylor D; Njoroge M; Lawrence N; Wiesner L; Waterson D; Witty MJ; Wittlin S; Street LJ; Chibale K
    J Med Chem; 2015 Sep; 58(18):7572-9. PubMed ID: 26322748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.